Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-10-07 00:00:00 ET · period of report 2022-10-06 · accession 0000899243-22-033326 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-07 | 2022-10-06 | DNA | Fallon Marie E. | See Remarks | S - Sale | $3.25 | -102.3K | 127.5K | -44% | -$332.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-10-06 | S | D | 102,254 | $3.25 | 127,534 | D | — | — |